Loading PYXS charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading PYXS comparable companies…
| PYXSPyxis Oncology, Inc.(opens in a new tab) | $0.12B | — | — | 97.1% | — | — | — |
|---|---|---|---|---|---|---|---|
| PTNPalatin Technologies Inc.(opens in a new tab) | $0.02B | $0.01B | — | 97.8% | −65.8% | 1.40× | — |
| EVMNEvommune, Inc.(opens in a new tab) | $0.24B | — | — | — | — | — | — |
| KROSKeros Therapeutics, Inc.(opens in a new tab) | $0.22B | $0.02B | −93.6% | — | −675.8% | 14.55× | — |
| SPROSpero Therapeutics, Inc.(opens in a new tab) | $0.06B | $0.01B | +9647.3% | — | 47.9% | 4.89× | 7.6× |
| Medianpeers, excl. PYXS | $0.14B | $0.01B | +4776.9% | 97.8% | −65.8% | 4.89× | 7.6× |